Approved Use: Aimovig™ is a prescription medicine used for the preventive treatment of migraine in adults.

Important Safety Information

Before starting Aimovig™, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your healthcare provider or pharmacist about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig™?

The most common side effects of Aimovig™ are pain, redness, or swelling at the injection site and constipation.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of Aimovig™. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Click here for Full Prescribing Information and Patient Product Information.

Approved Use

Aimovig™ is a prescription medicine used for the preventive treatment of migraine in adults.

Aimovig is proven to
reduce migraine days

for some, Aimovig cuts the number of monthly migraine days in half or more

What are the clinical results?

Aimovig is proven to reduce migraine days.

For some, Aimovig can cut the number of monthly migraine days in half or more.

6-7 fewer days on average

chronic migraine*

in a 3-month study, people taking Aimovig experienced 6-7 fewer monthly migraine days on average (vs. ~4 for placebo)

*15+ headache days per month, of which at least 8 were migraine days on average

3-4 fewer days on average

episodic migraine

in a 6-month study, people taking Aimovig experienced 3-4 fewer monthly migraine days on average (vs. ~2 for placebo)

4-14 migraine days per month on average

for some, Aimovig cut monthly migraine days by 50% or more

In a 3-month study, ~40% of people with chronic migraine* taking Aimovig cut their monthly migraine days by 50% or more (vs. 24% for placebo)

In a 6-month study, up to 50% of people with episodic migraine taking Aimovig cut their monthly migraine days by 50% or more (vs. 27% for placebo)

*Chronic migraine is defined as 15 or more headache days per month, of which at least 8 were migraine days.
Episodic migraine is defined as 4-14 migraine days per month.

contact us here 1-833-AIMOVIG (1-833-246-6844)
8 AM-8 PM ET, Mon-Fri

Important Safety Information

Before starting Aimovig™, tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your healthcare provider or pharmacist about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig™?

The most common side effects of Aimovig™ are pain, redness, or swelling at the injection site and constipation.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of Aimovig™. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Click here for Full Prescribing Information and Patient Product Information.

Approved Use

Aimovig™ is a prescription medicine used for the preventive treatment of migraine in adults.